IRIS
Pizzato, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.677
AS - Asia 1.620
EU - Europa 1.206
SA - Sud America 324
Continente sconosciuto - Info sul continente non disponibili 161
AF - Africa 46
OC - Oceania 2
Totale 8.036
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.617
SG - Singapore 682
IT - Italia 339
CN - Cina 320
VN - Vietnam 306
BR - Brasile 263
RU - Federazione Russa 185
UA - Ucraina 99
FI - Finlandia 97
DE - Germania 87
FR - Francia 85
GB - Regno Unito 72
LV - Lettonia 61
SE - Svezia 55
IN - India 54
HK - Hong Kong 50
KR - Corea 41
NL - Olanda 33
CA - Canada 30
ID - Indonesia 29
BD - Bangladesh 25
AR - Argentina 24
TR - Turchia 24
AT - Austria 18
PL - Polonia 18
IQ - Iraq 17
JP - Giappone 15
MX - Messico 14
EC - Ecuador 13
ZA - Sudafrica 12
ES - Italia 9
JO - Giordania 8
VE - Venezuela 8
CL - Cile 7
TN - Tunisia 7
BG - Bulgaria 6
CZ - Repubblica Ceca 6
PK - Pakistan 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
CO - Colombia 4
CR - Costa Rica 4
EG - Egitto 4
HR - Croazia 4
HU - Ungheria 4
KE - Kenya 4
LB - Libano 4
LT - Lituania 4
TW - Taiwan 4
AL - Albania 3
BY - Bielorussia 3
CH - Svizzera 3
GR - Grecia 3
IE - Irlanda 3
IL - Israele 3
JM - Giamaica 3
MA - Marocco 3
PY - Paraguay 3
TH - Thailandia 3
AU - Australia 2
AZ - Azerbaigian 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
IR - Iran 2
KZ - Kazakistan 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
PH - Filippine 2
PS - Palestinian Territory 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BE - Belgio 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GM - Gambi 1
GT - Guatemala 1
KG - Kirghizistan 1
LY - Libia 1
MK - Macedonia 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
PR - Porto Rico 1
RS - Serbia 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 7.877
Salva come PNG Salva come JPEG
Città #
Ashburn 516
Fairfield 508
Singapore 441
Chandler 281
Woodbridge 249
Seattle 230
Jacksonville 221
San Jose 219
Wilmington 192
Cambridge 176
Houston 167
Columbus 150
Santa Clara 141
Dallas 136
Council Bluffs 111
Ann Arbor 108
Trento 92
Moscow 87
Princeton 84
Ho Chi Minh City 83
San Mateo 81
Los Angeles 78
Beijing 67
Hanoi 66
New York 64
Riga 61
The Dalles 55
Lauterbourg 54
Helsinki 47
Munich 38
Boardman 37
Hong Kong 37
Seoul 36
Orem 30
Milan 28
Chicago 26
Como 26
San Diego 25
São Paulo 25
Rome 24
London 23
Da Nang 21
Jakarta 21
Dearborn 20
Buffalo 18
Chennai 18
Hefei 16
Redondo Beach 15
Warsaw 15
Montreal 14
Tokyo 14
Dong Ket 12
Frankfurt am Main 12
Brooklyn 11
Haiphong 11
Johannesburg 11
Vienna 11
Verona 10
Lappeenranta 9
Mumbai 9
San Paolo di Civitate 9
St Louis 9
Amsterdam 8
Falkenstein 8
Guangzhou 8
Mexico City 8
Poplar 8
Atlanta 7
Elk Grove Village 7
Hillsboro 7
Izmir 7
Nuremberg 7
Turin 7
Turku 7
Denver 6
Jinan 6
Phoenix 6
Rio de Janeiro 6
Shanghai 6
Sofia 6
Stockholm 6
Tashkent 6
Washington 6
Belo Horizonte 5
Biên Hòa 5
Brasília 5
Bremen 5
Dhaka 5
Düsseldorf 5
Fort Worth 5
Fremont 5
Miami 5
New Delhi 5
Quito 5
Salt Lake City 5
Toronto 5
Baghdad 4
Brno 4
Brugherio 4
Can Tho 4
Totale 5.630
Salva come PNG Salva come JPEG
Nome #
A Community Study of SARS-CoV-2 Detection by RT-PCR in Saliva: A Reliable and Effective Method 227
HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation 219
A bipartite structural organization defines the SERINC family of HIV-1 restriction factors 218
SERINC5 as a new restriction factor for human immunodeficiency virus and murine leukemia virus 214
SARS-CoV-2 and the Host Cell: A Tale of Interactions 204
SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins 202
Galanin pathogenic mutations in temporal lobe epilepsy 199
The antiviral activity of rodent and lagomorph SERINC3 and SERINC5 is counteracted by known viral antagonists 181
Mechanical activation of Efavirenz: the effects on the dissolution and inhibitory behavior 179
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 176
The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild 176
Retroviral factors promoting infectivity. 175
Centriolar distal appendages activate the centrosome-PIDDosome-p53 signalling axis via ANKRD26 175
Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer 173
The antagonism of HIV Nef to SERINC5 particle infectivity restriction involves the counteraction of virion-associated pools of the restriction factor 170
Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells. 166
The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles 166
S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3 165
Gene Therapy of Glioblastoma Multiforme with a Bicistronic Retroviral Vector Expressing Human IL-2 and HSV-tK. 158
Effect of High-Energy Milling on the Dissolution of Anti-HIV Drug Efavirenz in Different Solvents 156
Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans. 153
Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration 153
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity 149
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals 140
Development of a suspension packaging cell line for production of high titre, serum-resistant murine leukemia virus vectors. 138
Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef. 137
TRIM5 is an innate immune sensor for the retrovirus capsid lattice. 135
Effect of differential growth conditions on the dTTP pool size in herpes simplex virus-infected Vero cells. 134
Cyclosporine blocks incorporation of HIV-1 envelope glycoprotein into virions. 133
A one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants. 133
Progress with retroviral gene vectors. 128
Insertion of targeting domains into the envelope glycoprotein of Moloney murine leukemia virus (MoMLV)-based vectors modulates the route of mCAT-1-mediated viral entry. 127
Viral particles imaging through evanescent wave scattering in a total internal reflection laser microscope 126
Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles. 122
Nef enhances human immunodeficiency virus type 1 infectivity in the absence of matrix. 118
Heparin binds to murine leukemia virus and inhibits Env-independent attachment and infection. 117
Determination of HPRT mutant frequency and molecular analysis of T-lymphocyte mutants derived from coke-oven workers. 116
Quantification of reverse transcriptase activity by real-time PCR as a fast and accurate method for titration of HIV, lenti- and retroviral vectors. 116
Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research. 115
Molecular cloning, complete sequence, and biological characterization of a xenotropic murine leukemia virus constitutively released from the human B-lymphoblastoid cell line DG-75. 115
Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41. 112
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine 109
Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancer. 109
The carboxyl-terminus of human immunodeficiency virus type 2 circulating recombinant form 01_AB capsid protein affects sensitivity to human TRIM5α. 109
Localization to detergent-resistant membranes and HIV-1 core entry inhibition correlate with HIV-1 restriction by SERINC5 108
MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1. 103
A Conserved Acidic Residue in the C-Terminal Flexible Loop of HIV-1 Nef Contributes to the Activity of SERINC5 and CD4 Downregulation 102
Doxycycline Inhibition of a Pseudotyped Virus Transduction Does Not Translate to Inhibition of SARS-CoV-2 Infectivity 101
Herpes simplex virus chronically infected human T lymphocytes are susceptible to HIV-1 superinfection and support HIV-1 pseudotyping. 99
Host Restriction Factors Modulating HIV Latency and Replication in Macrophages 94
The activity of Nef on HIV-1 infectivity. 94
Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction. 83
Trends and symptoms of SARS-CoV-2 infection: a longitudinal study on an Alpine population representative sample 81
Retrovirus vectors. 78
Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals 75
Prospective epidemiological, molecular, and genetic characterization of a novel coronavirus disease in the Val Venosta/Vinschgau: the CHRIS COVID-19 study protocol 71
The impact of infection risk communication format on tourism travel intentions during COVID-19 70
Influence of Different Glycoproteins and of the Virion Core on SERINC5 Antiviral Activity 57
A Two-Step Ion-Exchange Process for Modified Mechanical Reinforcement and Virucidal Functionalization of Glasses 46
Ten questions concerning dynamic sensory variation in salutogenic building design 31
Totale 8.036
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.654
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 531
Totale 34.185
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022459 0 32 8 20 12 31 7 106 48 49 59 87
2022/2023607 63 68 6 69 52 87 9 54 113 35 31 20
2023/2024332 20 20 18 20 34 84 21 22 5 13 12 63
2024/20251.332 17 11 75 247 79 166 115 82 137 234 76 93
2025/20262.864 184 82 330 476 362 186 519 81 214 268 86 76
2026/2027208 49 159 0 0 0 0 0 0 0 0 0 0
Totale 8.036